Navigation Links
News from the November/December Issue of Molecular Medicine
Date:11/9/2009

Studying Genetic Variance Across the World is Critical in Understanding the Effects of Genes

(Vocus) November 9, 2009 -- Understanding patients’ ancestries can be extraordinarily valuable when analyzing and interpreting scientific results. In a multi-center genetics study that scanned the genomes of 4,000 people throughout Europe and found clear regional differences, Drs. Chao Tian and Michael F. Seldin of the University of California, Davis, in collaboration with Peter K. Gregersen, MD, of The Feinstein Institute for Medical Research, identified allele frequency differences among ethnic groups and subgroups. The finding, published in the November/December issue of Molecular Medicine, is critical in the analysis of genetic studies because not knowing an individual’s ancestry could result in statistical errors that alter the outcome of the study.

“Until now, scientists have depended on a person’s knowledge of their ancestral roots when they study human populations to look for risk genes,” said Dr. Gregersen, head of the Center for Genomics and Human Genetics at the Feinstein Institute. But even among racial groups there can be significant differences in the frequencies of certain genetic alleles.

In another important study published in this issue of Molecular Medicine, investigators in The Netherlands and in Argentina conducted the first study of a metabolic disorder called Erythropoietic Protoporphyria (EPP) in a sample of Argentinean patients. They identified several novel mutations that could eventually lead to new therapies for this serious condition. People with EPP have an accumulation of protoporphyin in their red blood cells, plasma, liver and bile. This causes serious photosensitivity that can lead to burning, itching, swelling and painful skin in sun-exposed areas.

Other intriguing studies appearing in the journal include stem cell expression patterns in endometriosis; and that the hunger hormone, ghrelin (proven to contain potent anti-inflammatory effects), prevented radiation-induced injury.

Molecular Medicine (www.molmed.org) is published by The Feinstein Institute for Medical Research. The peer-reviewed journal strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis and prevention. The journal, a bimonthly publication, serves as a forum through which scientists and researchers can communicate recent discoveries to a multi-disciplinary, international audience interested in understanding and curing disease.

To listen to the latest podcast on these studies visit www.molmed.org/podcast.html.

Contact: Veronica J. Davis, Communications Editor, 516-562-2670

# # #

Read the full story at http://www.prweb.com/releases/Molecular_Medicine/genetics/prweb3180324.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Annals of Internal Medicine tip sheet for Aug. 21, 2007, issue
2. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
3. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
4. AHCA: Rescinding $2.7 Billion Medicare Cuts Top Issue for Fall Legislative Agenda
5. Jump in Youth Suicide Prompts National Childrens Charity KidsPeace to Issue Tips on Prevention, Warning Signs
6. USC researcher identifies stem cells in tendons that regenerate tissue in animal model
7. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. American Red Cross Issues Blood Supply Alert
10. OSHA Issues Draft Ergonomics Guidelines on Preventing Musculoskeletal Injuries in Shipyards
11. Arbios Systems, Incs Q2/07 Analyst Review Issued by Scimitar Equity Research, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
News from the November/December Issue of Molecular Medicine
(Date:2/28/2017)... ... February 28, 2017 , ... Roxanna Cross will host ... the 11th Annual RISE Nashville Summit. RISE Nashville is the healthcare industry’s premier ... strategies. , The discussion will include best practices for accurate identification and capture ...
(Date:2/27/2017)... ... February 27, 2017 , ... Anahata ... Spiritual Awakening, is happy to announce her “Spring Rejuvenation in Sedona” personally ... individual customized retreats offer the winter-weary soul an excellent opportunity to come out ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... an overview on laser diffraction analysis as a tool to characterize particle size ... and potential to obtain improved results and novel scientific findings. It describes methods ...
(Date:2/27/2017)... San Francisco, CA (PRWEB) , ... February 27, ... ... Area center for hair transplantation therapy, is proud to announce a new informational ... popular hair therapy procedures. Follicular Unit Extraction (FUE) hair transplant and Follicular Unit ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... OCEAN VIEW, Delaware , February 27, 2017 ... (Software, Hardware, Services), By Product (Enterprise Based, Site Based), By Delivery Mode ... Research Organizations, Healthcare Providers), Industry Analysis Report, Regional Outlook (U.S., ... , Poland , Russia , ... Japan , South Korea , Taiwan ...
(Date:2/27/2017)... , Feb. 27, 2017   Royal Philips ... a global leader in health technology, today announced ... Administration (FDA) to market its ElastQ Imaging capability, ... of ultrasound systems. ElastQ Imaging enables simultaneous imaging ... is essential for the diagnosis of various liver ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
Breaking Medicine Technology: